ZORAPNA Trademark

Trademark Overview

On Friday, December 2, 2016, a trademark application was filed for ZORAPNA with the United States Patent and Trademark Office. The USPTO has given the ZORAPNA trademark a serial number of 87254848. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 7, 2025. This trademark is owned by Pfizer Inc.. The ZORAPNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
zorapna

General Information

Serial Number87254848
Word MarkZORAPNA
Filing DateFriday, December 2, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 7, 2025
Registration Number5546629
Registration DateTuesday, August 21, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 7, 2025
Primary Code005
First Use Anywhere DateWednesday, July 12, 2017
First Use In Commerce DateWednesday, July 12, 2017

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, March 2, 2017ASSIGNED TO EXAMINER
Wednesday, March 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2016NEW APPLICATION ENTERED
Wednesday, December 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 30, 2018SOU EXTENSION 2 GRANTED
Tuesday, April 18, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 20, 2017SOU TEAS EXTENSION RECEIVED
Monday, November 20, 2017SOU EXTENSION 1 FILED
Monday, November 20, 2017SOU EXTENSION 1 GRANTED
Wednesday, November 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 30, 2018SOU TEAS EXTENSION RECEIVED
Monday, April 30, 2018SOU EXTENSION 2 FILED
Tuesday, August 21, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 26, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, June 26, 2018USE AMENDMENT FILED
Wednesday, July 18, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 18, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 19, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 20, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 21, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 7, 2025CANCELLED SEC. 8 (6-YR)
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

zorapna cancer treatment preparations pharmaceutical